Re: Low Dose Chemotherapy with NO SIDE EFFECTS


J wrote:

> All I can find is a small (30 ) perhaps carefully selected patients in
> Uruguay
> Cancer Chemother Pharmacol (2004) 53: 220-224
> Insulin-induced enhancement of antitumoral response to methotrexate in
> breast cancer patients
>
> Abstract Purpose: It has been reported that insulin increases the cytotoxic
> effect in vitro of methotrexate by as
> much as 10,000-fold. The purpose of this study was to explore the clinical
> value of insulin as a potentiator of
> methotrexate. Patients and methods: Included in this prospective,
> randomized clinical trial were 30 women
> with metastatic breast cancer resistant to fluorouracil + Adriamycin +
> cyclophosphamide and also resistant to
> hormone therapy with measurable lesions. Three groups each of ten patients
> received two 21-day courses of the
> following treatments: insulin + methotrexate, methotrexate, and insulin,
> respectively. In each patient, the size
> of the target tumor was measured before and after treatment according to
> the Response Evaluation Criteria
> In Solid Tumors. The changes in the size of the target tumor in the three
> groups were compared statistically.
>
> Results: Under the trial conditions, the methotrexate treated group and the
> insulin-treated group responded
> most frequently with progressive disease. The group treated with insulin +
> methotrexate responded most
> frequently with stable disease. The median increase in tumor size was
> significantly lower with insulin +
> methotrexate than with each drug used separately.
> Discussion: Our results confirmed in vivo the results of previous in vitro
> studies showing clinical evidence that
> insulin potentiates methotrexate under conditions where insulin alone does
> not promote an increase in tumor
> growth. Therefore, the chemotherapy antitumoral activity must have been
> enhanced by the biochemical
> events elicited in tumor cells by insulin. Conclusions: In
> multidrug-resistant metastatic breast cancer, methotrexate
> + insulin produced a significant antitumoral response that was not seen
> with either methotrexate or
> insulin used separately.

My point, precisely, J.

We do need more clinical trials to verify the heretofore anecdotal
results.

That's why Elka Best Foundation came into existence.

Rachel Best
Executive Director
The Elka Best Foundation

.

Relevant Pages

  • Re: Beta-cell burnout?
    ... One time response may be very different from daily use over a period of years. ... "One limitation of our study is that we do not know whether the results can be generalized to all patients with type 2 diabetes, notably those with a longer disease duration and more complex therapy (combination of oral antidiabetic agents, combination of antidiabetic tablets and insulin, or insulin only). ...
    (alt.support.diabetes)
  • Re: Low Dose Chemotherapy with NO SIDE EFFECTS
    ... > use of kinder, gentler chemotherapy. ... It has been reported that insulin increases the cytotoxic ... effect in vitro of methotrexate by as ... The changes in the size of the target tumor in the three ...
    (sci.med.diseases.cancer)
  • Re: Low Dose Chemotherapy with NO SIDE EFFECTS
    ... he laid out a program of surgery and chemotherapy for me ... It has been reported that insulin increases the ... > effect in vitro of methotrexate by as ... The changes in the size of the target tumor in the three ...
    (sci.med.diseases.cancer)
  • Re: A test for Glass318
    ... glucose in such a way that energy is released in the form of ATP, ... aminoacids and free fatty acids. ... e) Insulin is a hormone that your body calls whenever your ... Type 1A patients do not produce insulin because their bodies have ...
    (alt.support.diabetes)
  • Re: MUFA diet for T2D
    ... only MUFA-rich LFD with ALA also improved both insulin sensitivity and ... Glycaemic control in type II diabetic tube-fed patients with a new enteral ... enteral formula low in carbohydrates and high in monounsaturated fatty acids ...
    (alt.support.diabetes)